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The purpose of this study was to identify the cell populations involved in recovery from oral infections with
Candida albicans. Monoclonal antibodies specific for CD4 cells, CD8 cells, and polymorphonuclear leuko-
cytes were used to deplete BALB/c and CBA/CaH mice of the relevant cell populations in systemic circulation.
Monocytes were inactivated with the cytotoxic chemical carrageenan. Mice were infected with 108 C. albicans
yeast cells and monitored for 21 days. Systemic depletion of CD4 and CD8 T lymphocytes alone did not
increase the severity of oral infection compared to that of controls. Oral colonization persisted in animals
treated with head and neck irradiation and depleted of CD4 T cells, whereas infections in animals that
received head and neck irradiation alone or irradiation and anti-CD8 antibody cleared the infection in a
comparable fashion. The depletion of polymorphonuclear cells and the cytotoxic inactivation of mononuclear
phagocytes significantly increased the severity of oral infection in both BALB/c and CBA/CaH mice. High levels
of interleukin 12 (IL-12) and gamma interferon (IFN-) were produced by lymphocytes from the draining
lymph nodes of recovering animals, whereas IL-6, tumor necrosis factor alpha, and IFN- were detected in the
oral mucosae of both naı¨ve and infected mice. The results indicate that recovery from oropharyngeal candi-
diasis in this model is dependent on CD4-T-cell augmentation of monocyte and neutrophil functions exerted
by Th1-type cytokines such as IL-12 and IFN-.
Clinical and laboratory studies have shown that neutrophils
(polymorphonuclear leukocytes [PMNLs]) play a major role in
host defense against systemic candidiasis (2, 3, 27, 31), al-
though recent work suggests that there is also a role for T cells
and their cytokines in recovery from this disease (45). Oral
candidiasis, however, has been consistently associated with de-
fects in the cell-mediated arm of the immune response (30, 33,
38). For example, children with thymic aplasia (DiGeorge syn-
drome) (11), patients suffering from human immunodeficiency
virus and AIDS (34, 49), and those undergoing therapeutic
chemotherapy and radiotherapy (42) are all more susceptible
to oral candidiasis.
The essential role for CD4 T cells in oral infection has
been demonstrated in an immunodeficient nu/nu mouse model
(C. S. Farah et al., submitted for publication). However, since
T cells do not kill Candida spp. directly, phagocytic cells clearly
play an important role in mediating clearance of the yeast from
the oral cavity. Both neutrophils and macrophages have been
shown to exert candidacidal activity and probably represent the
first line of defense against this yeast (16, 24). Indeed, neutro-
phil infiltration is the hallmark of oral candidal lesions (44, 51),
often forming microabscesses in the epithelium of infected
tissue.
Many patients with defects in neutrophil and macrophage
function are susceptible to oral candidiasis. Patients suffering
from primary immunodeficiencies such as hereditary myelo-
peroxidase deficiency have defects in neutrophil and macro-
phage activity due to an absence of myeloperoxidase from their
granules, while patients with Chediak-Higashi syndrome have
abnormal PMNLs with neutropenia and impaired chemotaxis
(55). These defects are thought to account for the impaired
killing of Candida albicans in these patients, making them
more susceptible to oral candidiasis.
Although the number and function of neutrophils and
monocytes in T-cell-deficient nu/nu mice are normal (22),
these mice could not clear an oral infection unless they were
reconstituted with T lymphocytes (Farah et al., submitted).
This finding suggests that, although phagocytic cells are
present in these mice, their anticandidal activity is dependent
on T-cell factors, most likely cytokines.
Therefore, the purposes of this study were to evaluate the
relative contributions of CD4 and CD8 T lymphocytes in an
inbred mouse model by monoclonal depletion and radiation
treatment and to explore the contribution of neutrophils and
macrophages to local defense against C. albicans.
MATERIALS AND METHODS
Mice. Specific-pathogen-free BALB/c and CBA/CaH female mice, 6 to 8
weeks of age, were purchased from the Animal Resources Centre, Perth, Aus-
tralia. These mice undergo routine microbiological screening and do not harbor
C. albicans in the gut. Animal experiments were approved by the Animal Ex-
perimentation Ethics Committee of the University of Queensland and carried
out in accordance with the National Health and Medical Research Council’s
Australian Code of Practice for the Care and Use of Animals for Scientific
Purposes, 1997. Mice were housed in standard cages and provided with food and
water ad libitum.
Yeast. C. albicans isolate 3630 was obtained from a patient with cutaneous
candidiasis, submitted to the Mycology Reference Laboratory at the Royal North
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Shore Hospital, Sydney, Australia, and stored at 70°C in Sabouraud’s broth–
15% (vol/vol) glycerol. For use, yeast cells were grown in Sabouraud’s broth for
48 h at room temperature with continuous agitation on a magnetic stirrer.
Blastospores were washed in phosphate-buffered saline (PBS) and adjusted to
the appropriate concentration for inoculation.
Oral infection. Mice were inoculated orally with 108 live C. albicans yeast cells
in 20 l of PBS. The infection was monitored by swabbing the oral cavity with
sterile cotton swabs moistened with sterile PBS and plating the yeast on Sab-
ouraud’s agar plates. Agar plates were incubated for 48 h at 37°C. All inoculation
and sampling procedures were carried out with the mice being under halothane
anaesthesia. CFU were counted on Sabouraud’s agar plates. The counts were
assigned into five groups correlating with the level of recoverable yeast from the
oral cavity. This process provided a semiquantitative measure of the level of
floridity of the infection. The scoring system used was as follows: 0, no detectable
yeast; 1, 1 to 10 CFU/plate; 2, 11 to 100 CFU/plate; 3, 101 to 1,000 CFU/plate;
and 4, 1,000 or more CFU/plate.
Histopathology. Mice were sacrificed at various time points throughout the
course of the experiment for histopathological examination of tissues. Skulls
were fixed in 10% neutral buffered formalin (pH 7.0) and decalcified in a 5%
formic acid and sodium formate mixture. Frontal sections of the skulls were
taken at approximately 3-mm intervals, with consecutive sections being stained
with hematoxylin and eosin and according to the periodic acid-Schiff technique.
Sections were examined by light microscopy.
CD4- and CD8-T-cell depletion. The hybridoma cell lines YTS191.1.2 and
YTS169.4.2.1 that produce monoclonal antibodies specific for mouse CD4 and
CD8 T lymphocytes, respectively (12, 41), were obtained courtesy of S. Cob-
bold, Sir William Dunn School of Pathology, University of Oxford, Oxford,
United Kingdom. Cell lines were seeded into a miniPERM Bioreactor (Heraeus,
Osterode/Harz, Germany) at 6  104 cells/ml in RPMI 1640 tissue culture
medium (Trace Biosciences, Castle Hill, New South Wales, Australia). Antibod-
ies were produced by the Antibody Facility at the Centre for Molecular and
Cellular Biology, University of Queensland. The concentration of protein was
calculated, and the supernatant was pretested in mice to determine the optimal
dose for depletion. Mice were depleted of lymphocytes by intraperitoneal injec-
tion of 300 g of antibody on day 2 and then every second day throughout the
course of the experiment. Control mice were injected with PBS. Depletion was
confirmed by fluorescence-activated cell sorting analysis of spleen and lymph
node cells on days 1 and 4 following antibody injection and at the termination of
the experiment using fluorescein isothiocyanate (FITC) conjugated and R-phy-
coerythrin (R-PE)-conjugated commercial antibodies specific for mouse CD4
and CD8, respectively.
Neutrophil depletion. A cell line (RB6-8C5) that secretes a monoclonal anti-
body specific for mouse neutrophils was obtained courtesy of R. Coffman,
DNAX Institute, Palo Alto, Calif. This rat immunoglobulin G2b (IgG2b) mono-
clonal antibody reacts with the Gr-1 surface antigen expressed on murine gran-
ulocytes but not with monocytes or lymphocytes (22, 43). The cell line was grown
as described above. The supernatant was used without further purification and
pretested to determine the optimal dose for depletion. Mice were depleted of
neutrophils by intraperitoneal administration of 300 g of the antibody prepa-
ration on day 2 and then at 48-h intervals until day 8. Control mice received a
similar course of PBS injections. Complete depletion of PMNLs was confirmed
by blood smears taken 1 and 4 days after treatment with the monoclonal antibody
and stained with May-Grunwald–Giemsa stain. Granulocyte and monocyte num-
bers were monitored throughout the course of the experiment with the use of
stained blood smears.
Macrophage inactivation. Carrageenan (type IV ; Sigma-Aldrich, St. Louis,
Mo.) was dissolved in sterile PBS at 5 mg/ml. The solution was heated to 56°C to
ensure complete solubilization. Mice were treated by intraperitoneal injection of
200 l (1 mg) of carrageenan 2 days prior to oral inoculation. Control mice
received 200 l of sterile PBS.
Intramucosal injection of depleting antibodies. Mice were injected with de-
pleting antibody for CD4 or CD8 directly into the oral tissues. A dose of 50 l
was injected intramucosally into the left and right buccal mucosae according to
the time scale noted above. The mice were infected with Candida yeast and
monitored for 21 days. Control animals received an injection of an equal volume
of PBS.
Radiation. Mice received head and neck irradiation equivalent to 800 rads
using a Cobalt-60 -radiation source. The mice were anesthetized and placed one
at a time in a protective lead chamber, with only the head in the direct path of
radiation. Mice were inoculated with the yeast immediately after irradiation as
described above.
Cell surface antigen staining. Lymphocytes were obtained by pressing either
spleens or lymph nodes through a sterile metal sieve, followed by filtration
through an 80-m- pore-size nylon mesh. The cells were resuspended in 6 ml of
PBS and separated on a Ficoll gradient by placing the cell suspension over 4 ml
of Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden). The gradient was
centrifuged at 700  g for 25 to 30 min at room temperature. The buffy coat
interface was carefully removed, washed twice in PBS, and resuspended in 1 ml
of PBS. Viable lymphocytes were counted in a hemocytometer after being
stained with trypan blue and adjusted to the appropriate concentration for
injection into recipient mice. Cells (106) were stained in 50 l of 0.1% PBS-NaN3
for 30 min at 4°C in the dark, using an appropriate concentration of a fluoro-
chrome-conjugated monoclonal antibody specific for a cell surface antigen or
isotype control (1 l of FITC-rat anti-mouse CD4 [IgG2a], 1.5 l of R-PE-rat
anti-mouse CD8 [IgG2a], 1 l of FITC-rat IgG2a isotype control Ig, and 1.5 l
of R-PE-rat IgG2a isotype control Ig; PharMingen, San Diego, Calif.). The cells
were washed twice in 0.1% PBS–NaN3, spun at 1,500 rpm for 5 min, and
resuspended in 500 l of 1% Formalin. Cells were analysed by fluorescence-
activated cell sorting.
Cytokine ELISA. Lymphocytes isolated from the submandibular and superfi-
cial cervical (SMSC) lymph nodes were cultured ex vivo for 3 days at 4  106
cells/ml in RPMI 1640 tissue culture medium, without antigen stimulation. The
supernatant was collected, filtered through a 0.8-m-pore-size filter, and stored
at 20°C until analyzed. The culture supernatant was assayed for interleukin 4
(IL-4), IL-10, IL-12, and gamma interferon (IFN-) by enzyme-linked immu-
nosorbent assay (ELISA) using matched-antibody pairs and recombinant cyto-
kines as standards. Briefly, immuno-polysorb microtiter plates (Nunc, Roskilde,
Denmark) were coated with capture rat monoclonal anti-IL-4 (IgG1), IL-10
(IgG1), IL-12 (IgG2a), or IFN- (IgG1) antibody (PharMingen) at 1 g/ml in
sodium bicarbonate buffer overnight at 4°C. The wells were washed and then
blocked with 1% bovine serum albumin–PBS before the culture supernatants
and the appropriate standard were added to each well. Biotinylated rat mono-
clonal anti-IL-4, IL-10, IL-12, or IFN- antibody (PharMingen) at 2 g/ml was
added as the second antibody. Detection was carried out with streptavidin per-
oxidase and tetramethylbenzidine. The results were expressed as net Candida-
induced counts from which the background was subtracted (Table 1).
RNA isolation. Tissues were homogenized in 1 ml of Ultraspec RNA reagent
(Biotecx Laboratories, Houston, Tex.) per 10 to 100 mg of tissue using an
Ultra-Turrax T25 homogenizer. The homogenate was held for 5 min at 4°C to
permit the complete dissociation of nucleoprotein complexes, at which time 200
l of chloroform was added and the tubes were vigorously shaken for 15 and then
stored on ice for another 5 min. The homogenate was centrifuged at 10,000  g
for 15 min at 4°C, and the upper phase was transferred to a new Eppendorf tube
without the interphase being disturbed. An equal volume of isopropanol was
added, and samples were stored on ice for 10 min and then centrifuged at
10,000  g for another 10 min at 4°C. The RNA pellet was washed twice in 1 ml
of 75% ethanol by vortexing and subsequent centrifugation at 10,000  g for 5
min at 4°C. The pellet was briefly dried for 5 to 10 min and dissolved in 25 l of
diethyl pyrocarbonate-water by vortexing for 1 min. The concentration and purity
of the RNA samples were determined by spectrophotometry at 260 and 280 nm
and then the samples were stored at 70°C until required.
RT-PCR. cDNA was prepared by reverse transcription (RT) of 1 g of each
RNA, using an oligo(dT)15 primer and avian myeloblastosis virus reverse tran-
scriptase (Promega, Madison, Wis.). Briefly, 4 l of 25 mM MgCl2 solution, 2 l
of 10 PCR amplification buffer (670 mM Tris-HCl, 166 mM [NH4]2SO4, 4.5%
Triton X-100, 2 mg of gelatin/ml [BioTech International, Western Australia,
Australia]), 2 l of a 10 mM concentration of a deoxynucleoside triphosphate mix,
0.5 l of RNasin, 0.75 l (15 U) of avian myeloblastosis virus reverse transcrip-
tase, 0.5 g of oligo(dT)15 primer, and 1 g of an mRNA sample were incubated
in a 20-l reaction mix at 42°C for 1 h, heated to 99°C for 5 min, and then cooled
TABLE 1. Cytokine production by BALB/c mouse SMSC lymph
node cells after oral infection with 108 C. albicans yeast cellsa
Day
postinfection
Mean (SEM) titer (pg/ml) of:
IL-4 IL-10 IL-12 IFN-
4 0 (0) 44.0 (5.1) 95.7 (4.2) 35.7 (10.3)
8 0 (0) 66.5 (5.9) 293.6 (35.9) 206.0 (16.6)
14 39.6 (1.2) 51.5 (18.2) 46.1 (5.2) 62.9 (29.2)
21 0 (0) 53.6 (6.8) 451.2 (20.6) 156.2 (7.7)
a Results are mean (SEM) cytokine titers in supernatants from lymphocytes
pooled from a minimum of three mice/group/time point. Lymph node cells were
cultured for 3 days ex vivo, and supernatants were analyzed by ELISA.
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on ice. cDNA was amplified by PCR in an amplification mix consisting of 2 l of
25 mM MgCl2, 2.5 l of 10 reaction buffer, 2 l of 25 a mM concentration of
the deoxynucleoside triphosphate mix, 0.5 U of Taq DNA polymerase, the
appropriate primer, and 1 l of cDNA in a total volume of 25 l. Negative
controls (without cDNA) were included for all primers used in each run. The
mixture was amplified using a PTC-100 programmable thermal cycler (MJ Re-
search, Inc., Watertown, Mass.). The amplification protocol was 35 to 40 cycles
of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min. Following amplification, 10
l of product was analyzed by electrophoresis through 2.5% (wt/vol) agarose
gels. The gels were stained with ethidium bromide, and the bands were visualized
using a UV transilluminator (GelDoc 2000; Bio-Rad, Regents Park, New South
Wales, Australia) with appropriate software (MultiAnalyst version 1.1; Bio-Rad,
Hercules, Calif.). Primer sequences for IL-2, IL-4, IL-6, IFN-, and tumor
necrosis factor alpha (TNF-) were obtained from published data (36) and
synthesized at the Australian Neuromuscular Research Institute, Perth, Western
Australia, Australia. The sequence for IL-10 was taken from published data (47)
and synthesized by Bresatec, Adelaide, South Australia, Australia.
Statistics. Quantitative data were analyzed using the statistical features of
GraphPad Prism version 2.01 (GraphPad, Inc., San Diego, Calif.). Student’s t test
and one-way analysis of variance (ANOVA) were used with a P of 	0.05 unless
otherwise specified.
RESULTS
CD4- and CD8-T-cell depletion. BALB/c and CBA/CaH
mice were depleted of either CD4 or CD8 or both CD4
and CD8 T cells by systemic administration of specific de-
pleting monoclonal antibodies. Initially, the antibodies achieved
approximately 90% depletion, which dropped to 50 to 60% by
day 8. Animals were infected with 108 C. albicans yeast cells 2
days following the first antibody injection. Oral colonization in
mice treated with depleting antibody was not significantly dif-
ferent from that of control animals, for both BALB/c and
CBA/CaH mice (Fig. 1). Although spleen and lymph node
T-cell populations were depleted, no effect was seen at the
mucosal surface with regard to the clearance or colonization of
the yeast in the oral cavity.
Intramucosal injection of CD4- and CD8-depleting antibod-
ies. Depleting antibodies were injected intramucosally into
BALB/c and CBA/CaH mice. Control animals were injected
with PBS to control for the effect of trauma. Both test and
control groups were subsequently inoculated 2 days later with
C. albicans. Treatment with CD4- and CD8-specific antibodies
had no effect on the severity of oral colonization; however, the
anti-CD4 antibody did prolong the infection compared to that
of control mice (data not shown).
Radiation and depletion of CD4 and CD8 T cells. Failure
to achieve an effect at the mucosal surface by systemic and
intramucosal injections of anti-CD4 and anti-CD8 antibodies
suggested that T cells resident in the oral mucosa were con-
tributing to host defense in these animals. In order to eliminate
the contribution of these resident T cells to responses in the
oral mucosa, BALB/c mice were treated with irradiation to the
head and neck and depleted systemically of either CD4 or
CD8 T cells. Control mice received an equivalent dose of
irradiation with no antibody treatment. All animals were in-
fected with 108 C. albicans yeast cells and monitored. Radia-
tion treatment significantly exacerbated the severity of the oral
infection with the yeast, as demonstrated by the high scores
seen on days 8 and 14 following infection. Mice that were
treated with irradiation alone were able to significantly elimi-
nate the yeast by day 21, as were those that were irradiated and
depleted of CD8 T cells (Fig. 2). Mice that received antibody
specific for CD4 T cells did not clear the infection on day 21.
This was significant (P 	 0.01) compared to the responses of
control mice that received irradiation alone and those that
received head and neck irradiation in conjunction with anti-
CD8 antibody (P 	 0.001). There was no difference in the
severity of the disease between control mice and nonirradiated
animals that were only systemically depleted at any time point
following infection (data not shown).
Cytokine production by lymph node cells using ELISA.
ELISA performed on culture supernatants of SMSC lympho-
cytes isolated from BALB/c mice following oral infection dem-
onstrated high levels of IL-12 on days 8 (293 pg/ml) and 21
(451 pg/ml), with moderate titers on day 4 (95 pg/ml) and low
levels on day 14 (46 pg/ml). Concentrations of IFN- were
moderate (35 to 206 pg/ml) and appeared to follow the pattern
of production of IL-12. Low levels of IL-10 (44 to 66 pg/ml)
were detected during the course of the infection, whereas IL-4
was detected only on day 14 (39 pg/ml). The concentrations of
IL-12 and IFN- were significantly higher than those of IL-4
and IL-10 on days 8 and 21 but not so on days 4 and 14 (Table
1).
Cytokine gene expression in oral tissues using RT-PCR.
Oral mucosae and tongues from BALB/c and CBA/CaH mice
were examined for the presence of RNA for IL-2, IL-4, IL-6,
IL-10, TNF-, and IFN-. Message for IL-2, IL-4, and IL-10
was undetectable in both naı¨ve and infected BALB/c mice.
IL-6, TNF-, and IFN- were detected in both naı¨ve and
infected oral tissue. The cytokine profile for CBA/CaH mice
was identical to that seen in BALB/c oral tissues.
Neutrophil depletion and macrophage inactivation. The ef-
fects of depletion of polymorphonuclear phagocytes and the
inactivation of monocytes/macrophages on the severity and
duration of oral colonization were determined in BALB/c and
CBA/CaH mice. In BALB/c mice, PMNL depletion alone in-
creased the severity of the infection compared to that of con-
trol mice (Fig. 3A). Results were significant (P 	 0.05) only on
days 1, 4, and 6. Macrophage inactivation alone significantly
increased the severity of the infection (P 	 0.01) compared to
that of controls on days 1, 2, 4, 6, and 8 (Fig. 4A). Eliminating
both phagocytic cell types significantly increased the severity of
the infection (P 	 0.01), but this increase was only slightly
greater than that seen after macrophage elimination alone
(Fig. 5A). PMNL depletion alone did not affect the severity of
the infection in CBA/CaH mice, nor did macrophage inactiva-
tion, except on day 1 (Fig. 3B and 4B). Ablation of both
neutrophils and macrophages was required to significantly in-
crease the severity of the infection in CBA/CaH mice (P 	
0.01) (Fig. 5B). The increase in severity of the oral infection
when both phagocytic cell types were inactivated was more
dramatic in CBA/CaH than in BALB/c mice (Fig. 5).
Histopathology of oral tissues following PMNL depletion
and macrophage inactivation. Histopathological examination
of oral tissues following neutrophil depletion and macrophage
inactivation revealed more abundant Candida hyphae pene-
trating the keratinized surface epithelium (Fig. 6). CBA/CaH
mice (Fig. 6B) were more heavily colonized than BALB/c mice
(Fig. 6A). There was evidence of high connective tissue papil-
lae and thickening and blunting of rete ridges. Polymorphonu-
clear microabscesses were not present, but transmigrating in-
traepithelial PMNLs were still observed.
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DISCUSSION
T lymphocytes have been implicated in recovery from sys-
temic (45), gastrointestinal (4, 5, 8, 9), and oral (10, 17) infec-
tions with C. albicans. In systemic infection, Th1 cytokines
correlate with resistance and Th2 cytokines correlate with
chronic disease (45), but less is known about the relative im-
portance and function of the T-cell subsets in oral infection.
In this study, depletion of CD4 and CD8 T cells signifi-
cantly decreased the numbers of these cells in the systemic
circulation but failed to demonstrate any role for these cell
populations in clearance of the yeast from the mucosal surface.
Animals treated with the depleting antibodies were no more
susceptible to oral challenge than control mice and cleared the
infection in a similar fashion. Comparable results have been
observed in experimental vaginal candidiasis (18, 19). Systemic
administration of anti-CD4 and anti-CD8 antibodies in these
studies effectively depleted the cells in systemic circulation but
had no effect on the vaginal C. albicans burden in mice after a
primary or secondary vaginal inoculation (19). It was suggested
that antibodies administered systemically were either unable to
reach the mucosa or did not reach the mucosa at high-enough
concentrations to achieve a detectable effect (18). However,
FIG. 1. Oral infection after CD4- and CD8-T-cell depletion by monoclonal antibodies in BALB/c (A) and CBA/CaH (B) inbred mice. Bars
represent scores (means  standard errors of the means [SEM]) for a minimum of 10 mice/group. Control mice received no antibody. Systemic
T-cell depletion did not significantly affect the severity of oral infection.
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Fidel et al. were able to demonstrate that intravaginal injection
of depleting antibodies resulted in T-cell depletion in both the
vagina and the systemic circulation (18). In the present study,
subset-specific monoclonal antibodies were injected into the
oral mucosae of BALB/c mice prior to C. albicans inoculation.
No significant effect on oral colonization was observed in an-
imals depleted of CD4 or CD8 T cells, although the dura-
tion of infection was slightly prolonged in mice depleted of
CD4 cells.
It is possible that the antibodies used in our experiments
were not effective against all T cells present in the oral mucosa,
since mucosal T cells are phenotypically and functionally dif-
ferent than those in the periphery (50). Flow cytometric anal-
ysis of T cells in oral mucosal epithelium shows that while /

T cells often predominate, the percentages of / T cells are
always considerably higher than in the periphery (25, 32, 39).
Moreover, mucosal /
 T cells are not identical to their sys-
temic counterparts (50). Both / and /
 T cells may be
resident in the oral mucosa, and both may have a role in the
clearance of the yeast from the mucosal surfaces (10, 17). In a
recent study, mice made deficient for /
 or / T cells (-or
-chain T-cell receptor knockout mice, respectively) were
more susceptible to orogastric candidiasis than immunocom-
petent controls (29). Nevertheless, irradiated mice depleted of
CD4 cells showed an impaired ability to clear the infection
compared to that of mice that were irradiated and depleted of
CD8 cells or irradiated controls. This result demonstrated
that the circulating CD4 T cells in mice were able to repop-
ulate the oral mucosa or draining lymph nodes and exert a
protective effect against the yeast.
In the present experiments, depletion of CD8 cells resulted
in a slightly accelerated clearance of yeast from the oral cavity,
but it remains to be established whether this was due to dele-
terious activity of the CD8 cells themselves or to some reg-
ulatory interaction with the CD4 cells. The precise role of
CD8 lymphocytes in host defense against candidiasis has not
yet been defined. Activated CD8 cells have been shown to
have the potential to lyse Candida-infected macrophages (48),
to reduce tissue damage associated with systemic infection (1),
and to have some protective effect against systemic infection,
although this potential was masked by the immunopathological
activities of CD4 T cells (13).
In an investigation of the role for IL-2 and IFN- in mucosal
candidiasis, Cantorna and Balish (5) failed to demonstrate a
substantial role for these cytokines in protecting the oral mu-
cosa from candidal infection, although CD4 T lymphocytes
were crucial in preventing candidiasis in this model. Cenci et
al. (9) have previously concluded that activation of Th1- but
not Th2-like responses may be responsible locally for control-
ling gastrointestinal candidiasis and generating protective im-
FIG. 2. Oral infection after CD4- and CD8-T-cell depletion in
irradiated BALB/c mice. Irradiated mice were treated with 800 rads of
-irradiation to the head and neck. Mice were depleted of either CD4
or CD8 T cells. Control mice received no antibody. Bars represent
scores (means  SEM) for a minimum of 10 mice/group. CD4-T-cell
depletion significantly prolonged the infection in irradiated mice com-
pared to that in control mice (●, P	 0.01) and that in mice treated with
anti-CD8 monoclonal antibody and irradiation ( , P 	 0.001). SEM
were 0 if error bars are not shown.
FIG. 3. Oral infection after PMNL depletion in BALB/c (A) and
CBA/CaH (B) mice. Test animals received monoclonal antibody in-
jections prior to C. albicans infection and then at 48-h intervals until
day 8. Control mice received no antibody. Bars represent scores
(means  SEM) for a minimum of 10 mice/group. Test mice were
significantly different from control mice ( , P 	 0.05) using Dunnett’s
test of the ANOVA.
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munity (9). They have also shown that mice deficient for the
IFN- receptor fail to mount protective Th1-mediated ac-
quired immunity upon mucosal challenge (8). The impaired
Th1-mediated resistance correlated with defective IL-12 re-
sponsiveness but not IL-12 production. Cenci et al. concluded
that IFN- was required for development of IL-12-dependent
protective Th1-dependent immunity.
IL-12 is produced by phagocytic cells and is known to act on
T lymphocytes by inducing proliferation and production of
cytokines such as IFN- (52–54). In turn, IFN- activates mac-
rophages and enhances their phagocytic abilities (35, 37).
IL-12 has been demonstrated to play a role in, and is an
obligatory factor for, Th1 induction. It acts directly on Th1
lymphocytes, and part of this activity is due to the induction of
IFN- production by T and NK cells. IL-12 and IFN- are
known to be involved in natural and acquired aspects of the
immune response (52), and it is perhaps some aspect of this
interaction that underlies the effector function of CD4 T cells
in the host response to oral candidiasis.
From the data presented in this study and those of others (5,
8, 9), there is little evidence that IL-2, IL-4, or IL-10 plays a
significant role in mucosal candidiasis. The production of Th1-
type cytokines such as IL-12, IFN-, and TNF- appears to be
relevant to the clearance of this yeast from the oral mucosal
tissues of infected mice.
FIG. 5. Oral infection after PMNL depletion and macrophage in-
activation in BALB/c (A) and CBA/CaH (B) mice. Test animals re-
ceived monoclonal antibody and carrageenan prior to C. albicans in-
fection. Control mice received no treatment. Bars represent scores
(means  SEM) for a minimum of 10 mice/group. Test mice were
significantly different from control mice ( , P 	 0.01) using Dunnett’s
test of the ANOVA.
FIG. 4. Oral infection after macrophage inactivation in BALB/c
(A) and CBA/CaH (B) mice. Test animals received carrageenan prior
to C. albicans infection. Control mice received no treatment. Bars
represent scores (means  SEM) for a minimum of 10 mice/group.
Test mice were significantly different from control mice ( , P 	 0.01)
using Dunnett’s test of the ANOVA.
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The role of innate defense mechanisms against oral candi-
diasis were examined in BALB/c and CBA/CaH mice by mono-
clonal antibody depletion of neutrophils and cytotoxic inacti-
vation of macrophages.
It is well established, by both clinical and experimental
studies, that either quantitative (3, 27) or qualitative (2, 31)
neutrophil defects are a predisposing factor to disseminated
candidiasis and that depletion of neutrophils significantly in-
creases the susceptibility to systemic candidiasis (20, 46). Neu-
trophils provide the first line of defense against systemic can-
didiasis, but their role in oral candidiasis has not been fully
explored. The RB6-8C5 monoclonal antibody is a rat IgG2b
reagent that selectively binds to and depletes mature mouse
neutrophils and eosinophils but not lymphocytes and macro-
phages (14, 43). In the present study, depletion of neutrophils
in BALB/c, but not in CBA/CaH, mice significantly increased
the severity of oral infection.
The other cell type with major anticandidal activity is the
macrophage. Macrophages are able to kill C. albicans through
several effector pathways, and their candidacidal state can be
enhanced by activation with a number of different cytokines.
Several techniques have been used to eliminate macrophages,
including liposomes containing dichloromethylene diphospho-
nate, silica, and carrageenan. In our experiments the use of
carrageenan was a simple and effective method to eliminate
macrophages in order to study their contribution to host resis-
tance against oral candidiasis.
Elimination of macrophages increases susceptibility to sys-
temic candidiasis (23, 27, 40), but few studies have assessed the
role of monocytic phagocytes in resistance to mucosal candi-
diasis. Impairment of macrophage function with poly(I-C) in-
creased the susceptibility of scid mice to disseminated candi-
diasis of endogenous origin (gastrointestinal tract) (26, 28), but
immunocompetent controls were resistant to mucosal candidi-
asis after poly(I-C) treatment. In fact, interference with both
macrophage and neutrophil function was necessary to render
these mice susceptible to mucosal infection (28). In the present
experiment, concurrent depletion of neutrophils and elimina-
tion of macrophages also induced a substantial increase in
susceptibility in BALB/c and CBA/CaH mice. Although each
treatment alone significantly increased the susceptibility of
BALB/c mice, both were required to demonstrate an effect in
the CBA/CaH strain. This finding suggests that in CBA/CaH
mice either neutrophils or macrophages are capable of main-
taining an effective host response but that in BALB/c mice
there may be limitations in the production or function of these
cells that render them more susceptible to the effects of de-
pletion.
Neutrophils in infected oral tissue are the hallmark of C.
albicans infection, and activation of macrophages appears to
be necessary for the full expression of resistance to disease. It
was expected that depletion of either of these cells would lead
to a more pronounced exacerbation of the infection at the
mucosal surface. It is possible that each of these phagocytic
subsets can compensate for the absence of the other, thereby
containing the initial spread and allowing the T cells to exert
their functions. Additionally, it must be noted that a significant
effect of carrageenan administration is granulocytosis (23). It
has been reported that the number of PMNLs in peripheral
blood increased after carrageenan administration, possibly ex-
plaining the increased resistance of treated mice to systemic
candidiasis (23).
It is evident that neutrophils are important effector cells
against C. albicans (15) and that, together with macrophages,
they are probably responsible for the ultimate elimination of
the fungus. However, recent studies of humans (6, 7) and mice
(46) suggest that neutrophils are also capable of synthesizing
FIG. 6. Histopathological sections of BALB/c (A) and CBA/CaH
(B) oral tissue infected with 108 C. albicans yeast cells following PMNL
depletion and macrophage inactivation (day 4). Sections show abun-
dant Candida hyphae penetrating the surface epithelium, with the
absence of PMNL microabscesses. Sections were stained with periodic
acid-Schiff stain. Scale bars, 45 m.
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immunomodulatory cytokines such as IL-10 and IL-12. These
cytokines are secreted by neutrophils early in infection and are
therefore important in the generation of the anticandidal Th-
cell response, which in turn modulates the functions of neu-
trophils. In our work, it is possible that IL-12 production by
neutrophils selected a Th1-type response by T cells.
In conclusion, this article emphasizes the importance of
CD4 T lymphocytes in oral candidiasis and supports clinical
observations that link oral C. albicans infections to defects in
cell-mediated immunity. The data also support the role for
Th1-type cytokines and protective immunity in the resolution
of oral candidiasis in infected mice. It appears that the clear-
ance of an oral C. albicans infection is dependent on CD4-
T-cell augmentation of monocyte and neutrophil functions ex-
erted by Th1-type cytokines such as IL-12 and IFN-.
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